Ellevest, Inc. Beam Therapeutics Inc. Transaction History

Ellevest, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$36.73 - $51.6 $293 - $412	-8 Reduced 33.33%	16 $0
Q3 2022 Nov 02, 2022	BUY	$39.79 - $70.31 $596 - $1,054	15 Added 166.67%	24 $1,000
Q2 2022 Jul 18, 2022	BUY	$29.86 - $62.36 $59 - $124	2 Added 28.57%	9 $0
Q1 2022 Apr 19, 2022	SELL	$53.73 - $82.16 $268 - $410	-5 Reduced 41.67%	7 $0
Q4 2021 Jan 24, 2022	SELL	$68.02 - $99.06 $204 - $297	-3 Reduced 20.0%	12 $1,000
Q3 2021 Oct 19, 2021	BUY	$84.37 - $133.6 $168 - $267	2 Added 15.38%	15 $1,000
Q2 2021 Jul 13, 2021	BUY	$64.12 - $128.71 $833 - $1,673	13 New	13 $2,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.